ACON Aclarion Short-Term Debt to Capital

Brandmark of Aclarion Corp (ACON)

Aclarion (ACON) is developing an innovative AI system for analyzing MRI scans for back issues, ensuring seamless global deployment via a cloud subscription. The business relies on the US market, which eliminates the impact of sanctions and trade conflicts. This chart illustrates the price action, where the indicator equals 0.00, which, against a backdrop of slow physician adoption and insurance complexities, creates certain liquidity risks.

ACON - Aclarion Corp Short-Term Indebtedness to Equity over the range 04/28/2023 - 10/29/2026
Signature product of Aclarion, Inc.

This indicator assesses liquidity and financial stability by measuring the ratio of liabilities maturing within one year to equity, allowing the short-term debt-to-equity ratio to determine Aclarion (ACON) dependence on rapid refinancing to support the development of its high-precision spinal MRI analysis platform.